whole blood
-
not specified
RNA-seq; RT-qPCR; Sanger Sequencing; Clinical Sample Validation
circRNA39338 is validated as down-regulated in whole blood from HBV-related HCC patients compared with HBV asymptomatic carriers, consistent with RNA-seq. The study does not establish a specific mechanism or clinical utility for circRNA39338.
0.4773
The potential of CircRNA1002 as a biomarker in hepatitis B virus-related hepatocellular carcinoma.
combined biological and clinical study